Bristol Myers Squibb Stock Investor Sentiment
| BMY Stock | USD 48.30 0.46 0.96% |
Slightly above 55% of Bristol Myers' investor base is interested to short. The analysis of overall sentiment of trading Bristol Myers Squibb stock suggests that many investors are impartial at this time. Bristol Myers' investor sentiment overview provides quick insight into current market opportunities from investing in Bristol Myers Squibb. The current market sentiment, together with Bristol Myers' historical and current headlines, can help investors time the market. In addition, many technical investors use Bristol Myers Squibb stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Panic Vs Confidence
45
Panic | Confidence |
Today, several news technology companies offer sentiment data to assist traders in manufacturing news sentiment indicators for investment decisions. We partner with these technology firms in helping retail investors build forecasting models that use Bristol Myers' input sentiment indicators derived from textual data and news published on major financial information outlets and social sites. These indicators can be used to analyze time-dependent numerical information representing public perception toward Bristol Myers Squibb.
News SentimentNeutral | Hype SentimentNeutral | Insider SentimentDisposing |
Bristol Myers stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Bristol daily returns and investor perception about the current price of Bristol Myers Squibb as well as its diversification or hedging effects on your existing portfolios.
Bristol Historical Sentiment
Although Bristol Myers' investment sentiment alone cannot always predict changes in its future share prices, when combined with other fundamental and technical analysis, a better chance to time the market can be gained. Certain informational and emotional events regarding Bristol, such as negative comments on social media and news outlets, may cause fear in the market and push Bristol Myers' investors to sell their holdings. The opposite can also be true when favorable news is released; it may translate into optimism and boost the price of Bristol.
Bristol |
Bristol Myers Sentiment by Major News Outlets
Investor sentiment, mood or attitude towards Bristol Myers can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
Bristol Myers Squibb Historical Investor Sentiment
Investor biases related to Bristol Myers' public news can be used to forecast risks associated with an investment in Bristol. The trend in average sentiment can be used to explain how an investor holding Bristol can time the market purely based on public headlines and social activities around Bristol Myers Squibb. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Bristol Myers' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Bristol Myers and other traded tickers. The bigger the bubble, the more accurate the estimated score. Higher bars for a given day show more participation in the average Bristol Myers news discussions. The higher the estimate score, the more favorable the investor's outlook on Bristol Myers.
Bristol Myers Maximum Pain Price across 2024-04-19 Option Contracts
Bristol Myers' options can also be used to analyze investors' bias and current market sentiment in the context of behavioral finance. For example, Max pain usually refers to a trading concept that asserts that market manipulation can cause the market price of Bristol Myers close to the expiration of its current option contract to expire worthlessly. According to most research, about 35% of options are not executed, with roughly 50% traded out before expiration. So, Max pain occurs when market makers reach a net favorable position across all options at a strike price where option holders stand to lose the most money. By contrast, option sellers may reap the most after selling more options than buying, causing them to expire worthlessly. Please continue to view the detailed analysis of Bristol Myers' options.
Far too much social signal, news, headlines, and media speculation about Bristol Myers that are available to investors today. That information is available publicly through Bristol media outlets and privately through word of mouth or via Bristol internal channels. However, regardless of the origin, that massive amount of Bristol data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Bristol Myers news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Bristol Myers relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Bristol Myers' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Bristol Myers alpha.
Bristol Myers Performance against NYSE Composite
Price Growth (%) |
| Timeline |
| Bristol Myers dividend paid on 1st of February 2024 | 02/01/2024 |
1 | Disposition of 1050 shares by Hoch Lynelle of Bristol Myers subject to Rule 16b-3 | 03/08/2024 |
2 | Bristol Myers drug Zeposia fails Phase 3 study for Crohns disease | 03/28/2024 |
3 | MaxCyte Signs Strategic Platform License with Be Biopharma to Support the Development of Engineered B Cell Medicines | 04/02/2024 |
4 | PureTech launches Seaport, hoping to create Karuna 2.0 | 04/09/2024 |
5 | 2 High-Yield Dividend Stocks Billionaires Are Buying Hand Over Fist | 04/10/2024 |
6 | Building a Better Future Bristol Myers Squibb 2023 ESG Report | 04/11/2024 |
7 | SHAREHOLDER ALERT Pomerantz Law Firm Investigates Claims on Behalf of Investors of Bristol-Myers Squibb Company - BMY | 04/12/2024 |
8 | Preclinical Safety Signal Prompts FDA Clinical Hold on Neumora Schizophrenia Drug | 04/15/2024 |
9 | Asher Bio Closes 55 Million Series C Financing to Advance Lead Program into Phase 1b Clinical Trials | 04/16/2024 |
10 | US FDA mandates label updates on CAR-T cancer therapies | 04/18/2024 |
Check out Bristol Myers Hype Analysis, Bristol Myers Correlation and Bristol Myers Performance. You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Complementary Tools for Bristol Stock analysis
When running Bristol Myers' price analysis, check to measure Bristol Myers' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Bristol Myers is operating at the current time. Most of Bristol Myers' value examination focuses on studying past and present price action to predict the probability of Bristol Myers' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Bristol Myers' price. Additionally, you may evaluate how the addition of Bristol Myers to your portfolios can decrease your overall portfolio volatility.
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments | |
| Technical Analysis Check basic technical indicators and analysis based on most latest market data | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| FinTech Suite Use AI to screen and filter profitable investment opportunities | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators |
Is Bristol Myers' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Bristol Myers. If investors know Bristol will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Bristol Myers listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth (0.09) | Dividend Share 2.31 | Earnings Share 3.86 | Revenue Per Share 21.753 | Quarterly Revenue Growth 0.006 |
The market value of Bristol Myers Squibb is measured differently than its book value, which is the value of Bristol that is recorded on the company's balance sheet. Investors also form their own opinion of Bristol Myers' value that differs from its market value or its book value, called intrinsic value, which is Bristol Myers' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Bristol Myers' market value can be influenced by many factors that don't directly affect Bristol Myers' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Bristol Myers' value and its price as these two are different measures arrived at by different means. Investors typically determine if Bristol Myers is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Bristol Myers' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.